These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21983466)

  • 21. Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations.
    Galati G; Gentilucci UV; Mazzarelli C; Gallo P; Grasso RF; Stellato L; Afeltra A; Picardi A
    Am J Med Sci; 2011 Jul; 342(1):79-82. PubMed ID: 21642818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis].
    Valverde S; Antico F; Trabuio E; Basso D; Navaglia F; Orlandini E; Giacomini A; Manoni F; Gessoni G
    Recenti Prog Med; 2008; 99(7-8):348-53. PubMed ID: 18751613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
    Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
    Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results.
    Saour JN; Shoukri MM; Mammo LA
    Saudi Med J; 2009 Oct; 30(10):1286-90. PubMed ID: 19838435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genomic diagnosis of thrombophilia in women: clinical relevance].
    Luxembourg B; Lindhoff-Last E
    Hamostaseologie; 2007 Feb; 27(1):22-31. PubMed ID: 17279273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of screening on thrombophilia for patients with venous thrombosis.
    Paschôa AF; Guillaumon AT
    Int Angiol; 2006 Mar; 25(1):52-9. PubMed ID: 16520725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study.
    Mansilha A; Araújo F; Severo M; Sampaio SM; Toledo T; Albuquerque R
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):545-9. PubMed ID: 16061406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia.
    Johnson SM; Meyers RL
    J Pediatr Surg; 2001 Aug; 36(8):1146-9. PubMed ID: 11479844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital absence of the inferior vena cava and genetic coagulation abnormalities: a rare associated risk factor for recurrent idiopathic deep vein thrombosis.
    Parma M; Belotti D; Marinoni S; Pogliani EM
    Clin Appl Thromb Hemost; 2003 Oct; 9(4):347-8. PubMed ID: 14653446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.